Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Tenaya Therapeutics Inc (NQ: TNYA ) 1.985 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, Sep 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Tenaya Therapeutics Inc Tenaya Therapeutics Launches Operations of New Genetic Medicines Manufacturing Center to Support the Development of Potentially First-In-Class Cardiovascular Therapeutics June 16, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Present Preclinical Data on TN-301 HDAC6 Inhibitor at European Society of Cardiology Heart Failure 2022 Conference May 20, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update May 11, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Present Preclinical Data on Gene Therapy Programs and Platform Capabilities at the American Society of Gene and Cell Therapy 25th Annual Meeting May 03, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Present Preclinical Data on TN-401 PKP2 Gene Therapy Program at Heart Rhythm 2022 April 28, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Participate in Upcoming Investor Conferences March 24, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Provides Business Updates March 23, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Participate in Upcoming Investor Conferences January 31, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Provides 2022 Business Updates January 10, 2022 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Appoints Karah Parschauer, J.D., to Its Board of Directors and Joanna Auch as Senior Vice President of People and Culture December 22, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Announces the Addition of Dr. June Lee to its Board of Directors November 22, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Participate in Upcoming Piper Sandler 33rd Annual Virtual Healthcare Conference November 19, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Updates November 10, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Present Preclinical Data on Its Gene Therapy Programs at the ESGCT 28th Annual Congress October 12, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Participate in Upcoming Investor and Industry Conferences September 30, 2021 From Tenaya Therapeutics Via Business Wire Tenaya Therapeutics Reports Second Quarter 2021 Financial Results and Provides Business Updates September 08, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics to Present at Morgan Stanley 19th Annual Global Healthcare Conference August 31, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares August 03, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Tenaya Therapeutics Announces Pricing of Upsized Initial Public Offering July 29, 2021 From Tenaya Therapeutics, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.